Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ratnadeep Basu

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology|October 6, 2009
Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic functionRatnadeep Basu, Gavin Y Oudit, Xiuhua Wang, et al.
Circulation. Heart Failure|February 9, 2017
Novel Dominant-Negative Mutation in Cardiac Troponin I Causes Severe Restrictive CardiomyopathySaumya Shah, Haran Yogasundaram, Ratnadeep Basu, et al.
Journal of the American Heart Association|January 25, 2017
Females Are Protected From Iron-Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative StressSubhash K Das, Vaibhav B Patel, Ratnadeep Basu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 7, 2015
Divergent roles of matrix metalloproteinase 2 in pathogenesis of thoracic aortic aneurysmMengcheng Shen, Jiwon Lee, Ratnadeep Basu, et al.
Circulation|October 12, 2011
Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stressVijay Kandalam, Ratnadeep Basu, Linn Moore, et al.
Cardiovascular Research|December 22, 2012
Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterloadPavel Zhabyeyev, Manoj Gandhi, Jun Mori, et al.
Circulation Research|January 9, 2010
TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activationVijay Kandalam, Ratnadeep Basu, Thomas Abraham, et al.
Bioscience Reports|December 7, 2017
Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapySubhash K Das, Pavel Zhabyeyev, Ratnadeep Basu, et al.
Cardiovascular Research|April 3, 2014
Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunctionDong Fan, Abhijit Takawale, Ratnadeep Basu, et al.
Circulation. Heart Failure|May 21, 2014
Myocardial recovery from ischemia-reperfusion is compromised in the absence of tissue inhibitor of metalloproteinase 4Abhijit Takawale, Dong Fan, Ratnadeep Basu, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
American Journal of Physiology. Heart and Circulatory Physiology|October 6, 2009
Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic functionRatnadeep Basu, Gavin Y Oudit, Xiuhua Wang, et al.
Circulation. Heart Failure|February 9, 2017
Novel Dominant-Negative Mutation in Cardiac Troponin I Causes Severe Restrictive CardiomyopathySaumya Shah, Haran Yogasundaram, Ratnadeep Basu, et al.
Journal of the American Heart Association|January 25, 2017
Females Are Protected From Iron-Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative StressSubhash K Das, Vaibhav B Patel, Ratnadeep Basu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 7, 2015
Divergent roles of matrix metalloproteinase 2 in pathogenesis of thoracic aortic aneurysmMengcheng Shen, Jiwon Lee, Ratnadeep Basu, et al.
Circulation|October 12, 2011
Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stressVijay Kandalam, Ratnadeep Basu, Linn Moore, et al.
Cardiovascular Research|December 22, 2012
Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterloadPavel Zhabyeyev, Manoj Gandhi, Jun Mori, et al.
Circulation Research|January 9, 2010
TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activationVijay Kandalam, Ratnadeep Basu, Thomas Abraham, et al.
Bioscience Reports|December 7, 2017
Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapySubhash K Das, Pavel Zhabyeyev, Ratnadeep Basu, et al.
Cardiovascular Research|April 3, 2014
Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunctionDong Fan, Abhijit Takawale, Ratnadeep Basu, et al.
Circulation. Heart Failure|May 21, 2014
Myocardial recovery from ischemia-reperfusion is compromised in the absence of tissue inhibitor of metalloproteinase 4Abhijit Takawale, Dong Fan, Ratnadeep Basu, et al.
Pageof 5